Related Experiment Video

Updated: Jun 20, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Dendritic cells and their receptors in antitumor immune response

Raghvendra M Srivastava1, Ashok Khar

  • 1Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad-500007, India.

Current Molecular Medicine
|August 20, 2009
PubMed

Insights

Dendritic cells (DCs) are key immune cells that fight cancer by presenting antigens and directly killing tumor cells. Understanding DC receptors is crucial for developing effective cancer immunotherapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Biology

Background:

  • Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating antitumor immune responses.
  • DCs bridge innate and adaptive immunity, influencing various immune cells to combat cancer.
  • Recent findings highlight the direct cytotoxic capabilities of DCs against tumor cells.

Purpose of the Study:

  • To review the role of dendritic cells (DCs) in cancer immunotherapy.
  • To discuss receptors that mediate DC-mediated direct cytotoxicity.
  • To explore receptors influencing DC antigen presentation functions.

Main Methods:

  • Literature review of studies on dendritic cells in cancer immunotherapy.
  • Analysis of research on DC receptors involved in cytotoxicity and antigen presentation.
  • Synthesis of findings on the link between DC function and receptor stimulation.

Main Results:

  • DCs are pivotal in inducing antitumor immune responses through antigen presentation and direct tumor cell killing.
  • Specific DC receptors are identified that mediate direct cytotoxicity.
  • Other receptors significantly influence DC antigen presentation, enhancing immune responses.
  • DCs are increasingly recognized for their multifaceted roles in cancer eradication.

Conclusions:

  • Dendritic cells (DCs) are versatile immune cells with significant potential in cancer immunotherapy.
  • Targeting DC-stimulating receptors can enhance both direct cytotoxicity and antigen presentation for improved cancer treatment.
  • Further research into DC receptors is essential for advancing DC-based cancer therapies.

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview